Dana-Farber’s Breast Oncology Center shared a post on X:
“Highlights from the 2026 DF/HCC Breast and Gynecologic Cancer Symposium
The symposium brought together investigators, clinicians, and patient advocates for a full day of talks, posters, and discussion. Sessions covered topics ranging from genomics and cancer risk to drug resistance, tumor microenvironment, and immunology.
The program reflected the broad scope of research in breast and gynecologic cancers and the shared effort to advance patient care and outcomes.”
Other articles about breast cancer on OncoDaily.